- Home
- MBCN vs DCTH Comparison
MBCN vs DCTH Comparison
Compare MBCN & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MBCN
- DCTH
- Stock Information
- Founded
- MBCN 1901
- DCTH 1988
- Country
- MBCN United States
- DCTH United States
- Employees
- MBCN N/A
- DCTH N/A
- Industry
- MBCN Major Banks
- DCTH Medical/Dental Instruments
- Sector
- MBCN Finance
- DCTH Health Care
- Exchange
- MBCN Nasdaq
- DCTH Nasdaq
- Market Cap
- MBCN 274.2M
- DCTH 289.2M
- IPO Year
- MBCN N/A
- DCTH N/A
- Fundamental
- Price
- MBCN $34.70
- DCTH $9.57
- Analyst Decision
- MBCN Hold
- DCTH Strong Buy
- Analyst Count
- MBCN 1
- DCTH 5
- Target Price
- MBCN $35.00
- DCTH $22.60
- AVG Volume (30 Days)
- MBCN 22.3K
- DCTH 1.0M
- Earning Date
- MBCN 10-22-2025
- DCTH 11-04-2025
- Dividend Yield
- MBCN 2.43%
- DCTH N/A
- EPS Growth
- MBCN 48.42
- DCTH N/A
- EPS
- MBCN 2.61
- DCTH 0.03
- Revenue
- MBCN $75,400,000.00
- DCTH $79,603,000.00
- Revenue This Year
- MBCN $19.98
- DCTH $135.11
- Revenue Next Year
- MBCN $7.42
- DCTH $36.30
- P/E Ratio
- MBCN $13.26
- DCTH $279.37
- Revenue Growth
- MBCN 16.60
- DCTH 251.54
- 52 Week Low
- MBCN $22.74
- DCTH $8.12
- 52 Week High
- MBCN $35.50
- DCTH $18.23
- Technical
- Relative Strength Index (RSI)
- MBCN 61.90
- DCTH 53.83
- Support Level
- MBCN $32.19
- DCTH $8.12
- Resistance Level
- MBCN $35.50
- DCTH $9.39
- Average True Range (ATR)
- MBCN 0.82
- DCTH 0.46
- MACD
- MBCN -0.00
- DCTH 0.17
- Stochastic Oscillator
- MBCN 77.34
- DCTH 96.71
About MBCN Middlefield Banc Corp.
Middlefield Banc Corp is a bank holding company. It offers customers, banking services including checking, savings, negotiable order of withdrawal (NOW) accounts, money market accounts, time deposits, commercial loans, real estate loans, a variety of consumer loans, safe deposit facilities, and travelers' checks. It also provides online banking and bill payment services to individuals and online cash management services to business customers.
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.